Kelsey Thomas

Title(s)Assistant Adjunct Professor, Psychiatry
SchoolVc-health Sciences-schools
Address9500 Gilman Drive #
La Jolla CA 92093
vCardDownload vCard

    Collapse Biography 
    Collapse Education and Training
    UC San Diego, La JollaB.S.; B.A.08/2008Biochemistry and Cell Biology; Psychology
    University of Florida, GainesvillePh.D.08/2016Clinical Psychology, Neuropsychology
    VA San Diego/UCSD, San DiegoInternship07/2016Clinical Neuropsychology
    VA San Diego/UCSD, San DiegoPostdoctoral Fellowship09/2019Clinical Neuropsychology

    Collapse Overview 
    Collapse Overview
    Kelsey Thomas, PhD is an Assistant Professor of Psychiatry at UC San Diego School of Medicine and a Research Health Scientist at VA San Diego. She completed her doctoral training at University of Florida and completed her predoctoral internship and postdoctoral fellowship at VA San Diego/UCSD. Together with Dr. Katherine Bangen, they run the Neuropsychology of Vascular Aging and Alzheimer’s (NOVAA) Lab.

    Dr. Thomas’s research focuses on the preclinical and prodromal phases of Alzheimer’s disease and vascular cognitive impairment and understanding the best approaches for capturing subtle cognitive declines. She integrates biological markers (e.g., plasma, PET, CSF, MRI) of Alzheimer’s disease, vascular disease, and neurodegeneration into her work to better understand possible mechanisms of subtle cognitive changes.

    Dr. Thomas studies early cognitive changes associated with diabetes and other vascular risks as well as sociocultural factors that impact cognitive aging outcomes. Her research is funded by NIH/NIA, Department of Veterans Affairs Clinical Services Research and Development, and the Alzheimer’s Association.

    Collapse Research 
    Collapse Research Activities and Funding
    The impact of segregation and the mediating effects of vascular risk on 10-year cognitive and functional outcomes in Black/African American older adults enrolled in the ACTIVE study
    NIH/NIA R03AG085241Sep 15, 2023 - Sep 14, 2025
    Role: MPI
    Heterogeneity of subtle cognitive decline phenotypes in community-dwelling older adults
    NIH/NIA RF1AG082726Sep 1, 2023 - Aug 31, 2028
    Role: PI
    Subjective & objective cognitive decline in community-dwelling older adults
    Alzheimer's Association AARG-22-723000Jan 1, 2023 - Dec 31, 2025
    Role: PI
    Clinical symptoms associated with plasma AD biomarker profiles
    NIH/NIA P30AG062429Apr 1, 2021 - Mar 31, 2023
    Role: PI of Development Grant / REC Scholar
    Identifying best methods for the detection of subtle cognitive decline
    NIH/NIA R03AG070435Jan 15, 2021 - Dec 31, 2023
    Role: PI
    Impact of Diabetes on Cognitive and Perfusion Inefficiencies in Preclinical AD
    Department of Veterans Affairs/CSR&D IK2CX001865Oct 1, 2019 - Sep 30, 2024
    Role: PI
    Cognitive Process Scores to Improve Preclinical AD Detection
    Alzheimer's Association AARF-17-528918Nov 1, 2017 - Oct 31, 2020
    Role: PI
    ACTIVE Cognitive Training Trial: 20-Yr Follow-Up of Functioning, Health, & Dementia
    NIH/NIA R01AG056486Sep 15, 2017 - May 31, 2023
    Role: Co-I / Site PI

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Data-driven classification of cognitively normal and mild cognitive impairment subtypes predicts progression in the NACC dataset. Alzheimers Dement. 2024 Apr 04. Edmonds EC, Thomas KR, Rapcsak SZ, Lindemer SL, Delano-Wood L, Salmon DP, Bondi MW. PMID: 38574399.
      View in: PubMed   Mentions:    Fields:    
    2. Does Consumer Credit Precede or Follow Health Among Older Adults? An Investigation in the Advanced Cognitive Training for Independent and Vital Elderly (ACTIVE) Trial. Innov Aging. 2024; 8(3):igae016. Dean LT, Chung SE, Gross AL, Clay OJ, Willis SL, McDonough IM, Thomas KR, Marsiske M, Aysola J, Thorpe RJ, Felix C, Berkowitz M, Coe NB. PMID: 38511203; PMCID: PMC10953618.
      View in: PubMed   Mentions:
    3. Pulse pressure and APOE ε4 dose interact to affect cerebral blood flow in older adults without dementia. Cereb Circ Cogn Behav. 2024; 6:100206. Edwards L, Thomas KR, Weigand AJ, Edmonds EC, Clark AL, Brenner EK, Banks SJ, Gilbert PE, Nation DA, Delano-Wood L, Bondi MW, Bangen KJ. PMID: 38328026; PMCID: PMC10847851.
      View in: PubMed   Mentions:
    4. Type 2 Diabetes Moderates the Association Between Amyloid and 1-Year Change in Everyday Functioning in Older Veterans. J Alzheimers Dis. 2024; 97(1):219-228. Alshaheri Durazo A, Weigand AJ, Bangen KJ, Membreno R, Mudaliar S, Thomas KR, Department of Defense Alzheimer’s Disease Neuroimaging Initiative. PMID: 38160359.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    5. Regional White Matter Hyperintensities Relate to Specific Cognitive Abilities in Older Adults Without Dementia. Alzheimer Dis Assoc Disord. 2023 Oct-Dec 01; 37(4):303-309. Membreno R, Thomas KR, Calcetas AT, Edwards L, Bordyug M, Showell M, Stanfill M, Brenner EK, Walker KS, Rotblatt LJ, Brickman AM, Edmonds EC, Bangen KJ, Alzheimer’s Disease Neuroimaging Initiative. PMID: 38015423; PMCID: PMC10664788.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    6. Empirically derived psychosocial-behavioral phenotypes in Black/African American and Hispanic/Latino older adults enrolled in HABS-HD: Associations with AD biomarkers and cognitive outcomes. Alzheimers Dement. 2024 Feb; 20(2):1360-1373. Clark AL, Thomas KR, Ortega N, Haley AP, Duarte A, O'Bryant S, HABS-HD Study Team. PMID: 37990803; PMCID: PMC10917046.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    7. Does Consumer Credit Precede or Follow Changes in Cognitive Impairment Among Older Adults? An Investigation in the Advanced Cognitive Training for Independent and Vital Elderly (ACTIVE) Trial. J Aging Health. 2023 10; 35(9_suppl):84S-94S. Dean LT, Chung SE, Gross AL, Clay OJ, Willis SL, Crowe M, McDonough IM, Thomas KR, Marsiske M, Aysola J, Thorpe RJ, Felix C, Berkowitz M, Coe NB. PMID: 37994853.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    8. Associations Between Body Mass Index and Cognitive Change in the ACTIVE Study: Variations by Race and Social Determinants of Health. J Aging Health. 2023 10; 35(9_suppl):59S-73S. Aiken-Morgan AT, McDonough IM, Parisi JM, Clay OJ, Thomas KR, Rotblatt LJ, Thorpe RJ, Marsiske M. PMID: 37994849.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    9. Research Letter: TBI Severity Moderates the Association Between Subjective and Objective Attention in Older Veterans. J Head Trauma Rehabil. 2023 Sep 08. Rantins P, Ly M, Clark AL, Weigand AJ, Alshaheri Durazo A, Merritt VC, Bangen KJ, Thomas KR, Department of Defense Alzheimer's Disease Neuroimaging Initiative. PMID: 37712765; PMCID: PMC10920393.
      View in: PubMed   Mentions:    Fields:    
    10. Parental, caregiving, and family leave during clinical neuropsychology postdoctoral training: Recommendations and guidelines from the Women in Neuropsychology (WIN) committee and Education Advisory Committee (EAC) of the Society for Clinical Neuropsychology (SCN; APA division 40). Clin Neuropsychol. 2024 Feb; 38(2):247-261. Kaseda ET, Arentoft A, Bangen KJ, Mahmood Z, Thomas K, Kim SH, Tan A, Prieto S, Dawson EL, Riegler K, Sullivan-Baca E, Ellison RL. PMID: 37270409.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    11. Greater accelerometer-measured physical activity is associated with better cognition and cerebrovascular health in older adults. J Int Neuropsychol Soc. 2023 11; 29(9):859-869. Bangen KJ, Calcetas AT, Thomas KR, Wierenga C, Smith CN, Bordyug M, Brenner EK, Wing D, Chen C, Liu TT, Zlatar ZZ. PMID: 36789631; PMCID: PMC10425574.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    12. Cognitive reserve moderates the association between cerebral blood flow and language performance in older adults with mild cognitive impairment. Neurobiol Aging. 2023 05; 125:83-89. Brenner EK, Thomas KR, Weigand AJ, Edwards L, Edmonds EC, Bondi MW, Bangen KJ, Alzheimer's Disease Neuroimaging Initiative. PMID: 36868071; PMCID: PMC10824498.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    13. APOE differentially moderates cerebrospinal fluid and plasma phosphorylated tau181 associations with multi-domain cognition. Neurobiol Aging. 2023 05; 125:1-8. Weigand AJ, Ortiz G, Walker KS, Galasko DR, Bondi MW, Thomas KR, Alzheimer's Disease Neuroimaging Initiative. PMID: 36780762.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    14. Brain Derived Neurotrophic Factor Interacts with White Matter Hyperintensities to Influence Processing Speed and Hippocampal Volume in Older Adults. J Alzheimers Dis. 2023; 93(1):141-149. Brenner EK, Weigand AJ, Edwards L, Thomas KR, Edmonds EC, Bondi MW, Bangen KJ, Alzheimer’s Disease Neuroimaging Initiative. PMID: 36970903; PMCID: PMC10200154.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    15. White Matter Hyperintensity Volume and Amyloid-PET Synergistically Impact Memory Independent of Tau-PET in Older Adults Without Dementia. J Alzheimers Dis. 2023; 94(2):695-707. Edwards L, Thomas KR, Weigand AJ, Edmonds EC, Clark AL, Walker KS, Brenner EK, Nation DA, Maillard P, Bondi MW, Bangen KJ, Alzheimer’s Disease Neuroimaging Initiative. PMID: 37302031; PMCID: PMC10357163.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    16. Associations between social determinants of health and 10-year change in everyday functioning within Black/African American and White older adults enrolled in ACTIVE. Alzheimers Dement (Amst). 2022; 14(1):e12385. Clark AL, Weigand AJ, Clay OJ, Owens J, Fiala J, Crowe M, Marsiske M, Thomas KR. PMID: 36514539; PMCID: PMC9732812.
      View in: PubMed   Mentions: 2  
    17. Subjective cognitive complaints are important in PD-MCI criteria: Associations with CSF markers and cognitive decline. Parkinsonism Relat Disord. 2023 01; 106:105221. Jones JD, Rivas R, Luna K, Ryczek CA, Thomas KR. PMID: 36442366; PMCID: PMC10775883.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    18. Comprehensive characterization of elevated tau PET signal in the absence of amyloid-beta. Brain Commun. 2022; 4(6):fcac272. Weigand AJ, Edwards LE, Thomas KR, Bangen KJ, Bondi MW, Alzheimer’s Disease Neuroimaging Initiative. PMID: 36382220; PMCID: PMC9651027.
      View in: PubMed   Mentions: 3  
    19. Baseline executive functioning moderates treatment-related changes in quality of life in veterans with posttraumatic stress disorder and comorbid traumatic brain injury. J Trauma Stress. 2023 02; 36(1):94-105. Crocker LD, Sullan MJ, Jurick SM, Thomas KR, Davey DK, Hoffman SN, Twamley EW, Jak AJ. PMID: 36204974.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    20. Cognitive dispersion is elevated in amyloid-positive older adults and associated with regional hypoperfusion. J Int Neuropsychol Soc. 2023 08; 29(7):621-631. Holmqvist SL, Thomas KR, Edmonds EC, Calcetas A, Edwards L, Bangen KJ, Alzheimer’s Disease Neuroimaging Initiative. PMID: 36093903; PMCID: PMC10008465.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    21. Tau levels are higher in objective subtle cognitive decline but not subjective memory complaint. Alzheimers Res Ther. 2022 08 22; 14(1):114. Thomas KR, Weigand AJ, Edwards LC, Edmonds EC, Bangen KJ, Ortiz G, Walker KS, Bondi MW, Alzheimer’s Disease Neuroimaging Initiative. PMID: 35996158; PMCID: PMC9394026.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    22. Longitudinal Intraindividual Cognitive Variability Is Associated With Reduction in Regional Cerebral Blood Flow Among Alzheimer's Disease Biomarker-Positive Older Adults. Front Aging Neurosci. 2022; 14:859873. Holmqvist SL, Thomas KR, Brenner EK, Edmonds EC, Calcetas A, Edwards L, Bordyug M, Bangen KJ. PMID: 35875798; PMCID: PMC9300445.
      View in: PubMed   Mentions: 3  
    23. Increased regional white matter hyperintensity volume in objectively-defined subtle cognitive decline and mild cognitive impairment. Neurobiol Aging. 2022 10; 118:1-8. Calcetas AT, Thomas KR, Edmonds EC, Holmqvist SL, Edwards L, Bordyug M, Delano-Wood L, Brickman AM, Bondi MW, Bangen KJ. PMID: 35809348; PMCID: PMC9838569.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    24. Practice Effects in Mild Cognitive Impairment Increase Reversion Rates and Delay Detection of New Impairments. Front Aging Neurosci. 2022; 14:847315. Sanderson-Cimino M, Elman JA, Tu XM, Gross AL, Panizzon MS, Gustavson DE, Bondi MW, Edmonds EC, Eppig JS, Franz CE, Jak AJ, Lyons MJ, Thomas KR, Williams ME, Kremen WS. PMID: 35547623; PMCID: PMC9083463.
      View in: PubMed   Mentions: 3  
    25. Cognitive practice effects delay diagnosis of MCI: Implications for clinical trials. Alzheimers Dement (N Y). 2022; 8(1):e12228. Sanderson-Cimino M, Elman JA, Tu XM, Gross AL, Panizzon MS, Gustavson DE, Bondi MW, Edmonds EC, Eglit GML, Eppig JS, Franz CE, Jak AJ, Lyons MJ, Thomas KR, Williams ME, Kremen WS, Alzheimer's Disease Neuroimaging Initiative. PMID: 35128027; PMCID: PMC8804942.
      View in: PubMed   Mentions: 7  
    26. Cognitive Heterogeneity and Risk of Progression in Data-Driven Subtle Cognitive Decline Phenotypes. J Alzheimers Dis. 2022; 90(1):323-331. Thomas KR, Bangen KJ, Weigand AJ, Ortiz G, Walker KS, Salmon DP, Bondi MW, Edmonds EC. PMID: 36120785; PMCID: PMC9661321.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    27. Interactive Effects of Pulse Pressure and Tau Imaging on Longitudinal Cognition. J Alzheimers Dis. 2022; 89(2):633-640. Weigand AJ, Macomber AJ, Walker KS, Edwards L, Thomas KR, Bangen KJ, Nation DA, Bondi MW, Alzheimer’s Disease Neuroimaging Initiative. PMID: 35938247; PMCID: PMC9904538.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    28. Arterial Stiffening Moderates the Relationship Between Type-2 Diabetes Mellitus and White Matter Hyperintensity Burden in Older Adults With Mild Cognitive Impairment. Front Aging Neurosci. 2021; 13:716638. Werhane ML, Thomas KR, Bangen KJ, Weigand AJ, Edmonds EC, Nation DA, Sundermann EE, Bondi MW, Delano-Wood L. PMID: 34759811; PMCID: PMC8574966.
      View in: PubMed   Mentions: 4  
    29. Objective subtle cognitive decline and plasma phosphorylated tau181: Early markers of Alzheimer's disease-related declines. Alzheimers Dement (Amst). 2021; 13(1):e12238. Thomas KR, Bangen KJ, Edmonds EC, Weigand AJ, Walker KS, Bondi MW, Galasko DR, Alzheimer's Disease Neuroimaging Initiative. PMID: 34692978; PMCID: PMC8515224.
      View in: PubMed   Mentions: 11  
    30. Higher cerebrospinal fluid tau is associated with history of traumatic brain injury and reduced processing speed in Vietnam-era veterans: A Department of Defense Alzheimer's Disease Neuroimaging Initiative (DOD-ADNI) study. Alzheimers Dement (Amst). 2021; 13(1):e12239. Clark AL, Weigand AJ, Bangen KJ, Thomas KR, Eglit GML, Bondi MW, Delano-Wood L, Alzheimer's Disease Neuroimaging Initiative. PMID: 34692979; PMCID: PMC8515227.
      View in: PubMed   Mentions: 8  
    31. When wrong answers lead us down the right path. Int Psychogeriatr. 2022 Nov; 34(11):959-961. Thomas KR, Au R. PMID: 34593071.
      View in: PubMed   Mentions:    Fields:    
    32. Diagnostic accuracy and differential associations between ratings of functioning and neuropsychological performance in non-Hispanic Black and White older adults. Clin Neuropsychol. 2022 02; 36(2):287-310. Graves LV, Edmonds EC, Thomas KR, Weigand AJ, Cooper S, Stickel AM, Zlatar ZZ, Clark AL, Bondi MW. PMID: 34499580; PMCID: PMC8849565.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    33. Intrusion errors moderate the relationship between blood glucose and regional cerebral blood flow in cognitively unimpaired older adults. Brain Imaging Behav. 2022 Feb; 16(1):219-227. Thomas KR, Weigand AJ, Cota IH, Edmonds EC, Wierenga CE, Bondi MW, Bangen KJ, Alzheimer’s Disease Neuroimaging Initiative. PMID: 34415491; PMCID: PMC8825619.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    34. Data-Driven vs Consensus Diagnosis of MCI: Enhanced Sensitivity for Detection of Clinical, Biomarker, and Neuropathologic Outcomes. Neurology. 2021 09 28; 97(13):e1288-e1299. Edmonds EC, Smirnov DS, Thomas KR, Graves LV, Bangen KJ, Delano-Wood L, Galasko DR, Salmon DP, Bondi MW. PMID: 34376506; PMCID: PMC8480404.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    35. Baseline sleep quality moderates symptom improvement in veterans with comorbid PTSD and TBI receiving trauma-focused treatment. Behav Res Ther. 2021 08; 143:103892. Sullan MJ, Crocker LD, Thomas KR, Orff HJ, Davey DK, Jurick SM, Twamley EW, Norman SB, Schiehser DM, Aupperle R, Jak AJ. PMID: 34091276.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    36. Elevated plasma neurofilament light predicts a faster rate of cognitive decline over 5 years in participants with objectively-defined subtle cognitive decline and MCI. Alzheimers Dement. 2021 10; 17(10):1756-1762. Bangen KJ, Thomas KR, Weigand AJ, Edmonds EC, Clark AL, Solders S, Delano-Wood L, Galasko DR, Bondi MW, Alzheimer's Disease Neuroimaging Initiative. PMID: 33860596; PMCID: PMC8517034.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    37. Adding cognition to AT(N) models improves prediction of cognitive and functional decline. Alzheimers Dement (Amst). 2021; 13(1):e12174. O'Shea DM, Thomas KR, Asken B, Lee AKW, Davis JD, Malloy PF, Salloway SP, Correia S, Alzheimer's Disease Neuroimaging Initiative. PMID: 33816757; PMCID: PMC8012408.
      View in: PubMed   Mentions: 6  
    38. Prediabetes Is Associated With Brain Hypometabolism and Cognitive Decline in a Sex-Dependent Manner: A Longitudinal Study of Nondemented Older Adults. Front Neurol. 2021; 12:551975. Sundermann EE, Thomas KR, Bangen KJ, Weigand AJ, Eppig JS, Edmonds EC, Wong CG, Bondi MW, Delano-Wood L. PMID: 33679574; PMCID: PMC7933503.
      View in: PubMed   Mentions: 12  
    39. Do Associations Between Vascular Risk and Mild Cognitive Impairment Vary by Race? J Aging Health. 2021 Jan 26; 898264320984357. Rotblatt LJ, Aiken-Morgan AT, Marsiske M, Horgas AL, Thomas KR. PMID: 33497299; PMCID: PMC8310897.
      View in: PubMed   Mentions: 5     Fields:    
    40. Elevated Inflammatory Markers and Arterial Stiffening Exacerbate Tau but Not Amyloid Pathology in Older Adults with Mild Cognitive Impairment. J Alzheimers Dis. 2021; 80(4):1451-1463. Clark AL, Weigand AJ, Thomas KR, Solders SK, Delano-Wood L, Bondi MW, Bernier RA, Sundermann EE, Banks SJ, Bangen KJ, Alzheimer’s Disease Neuroimaging Initiative. PMID: 33682714; PMCID: PMC9052932.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCells
    41. Entorhinal Perfusion Predicts Future Memory Decline, Neurodegeneration, and White Matter Hyperintensity Progression in Older Adults. J Alzheimers Dis. 2021; 81(4):1711-1725. Bangen KJ, Thomas KR, Sanchez DL, Edmonds EC, Weigand AJ, Delano-Wood L, Bondi MW, Alzheimer’s Disease Neuroimaging Initiative. PMID: 33967041; PMCID: PMC9462657.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    42. White Matter Microstructure is Associated with Serum Clusterin and Everyday Functioning in a Sample of Nondemented Older Adults. Curr Alzheimer Res. 2021; 18(14):1118-1126. Clark AL, Solders SK, Thomas KR, Bangen KJ. PMID: 34961443.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    43. Cognitive Practice Effects Delay Diagnosis; Implications for Clinical Trials. medRxiv. 2020 Nov 05. Sanderson-Cimino M, Elman JA, Tu XM, Gross AL, Panizzon MS, Gustavson DE, Bondi MW, Edmonds EC, Eglit GML, Eppig JS, Franz CE, Jak AJ, Lyons MJ, Thomas KR, Williams ME, Kremen WS, Alzheimer’s Disease Neuroimaging Initiative. PMID: 33173908; PMCID: PMC7654904.
      View in: PubMed   Mentions:
    44. Application of neuropsychological criteria to classify mild cognitive impairment in the active study. Neuropsychology. 2020 Nov; 34(8):862-873. Thomas KR, Cook SE, Bondi MW, Unverzagt FW, Gross AL, Willis SL, Marsiske M. PMID: 33197199; PMCID: PMC8376229.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    45. Incident Instrumental Activities of Daily Living Difficulty in Older Adults: Which Comes First? Findings From the Advanced Cognitive Training for Independent and Vital Elderly Study. Front Neurol. 2020; 11:550577. Feger DM, Willis SL, Thomas KR, Marsiske M, Rebok GW, Felix C, Gross AL. PMID: 33192982; PMCID: PMC7642324.
      View in: PubMed   Mentions: 11  
    46. APOE interacts with tau PET to influence memory independently of amyloid PET in older adults without dementia. Alzheimers Dement. 2021 01; 17(1):61-69. Weigand AJ, Thomas KR, Bangen KJ, Eglit GML, Delano-Wood L, Gilbert PE, Brickman AM, Bondi MW, Alzheimer's Disease Neuroimaging Initiative. PMID: 32886451.
      View in: PubMed   Mentions: 28     Fields:    Translation:Humans
    47. Association of anticholinergic medications and AD biomarkers with incidence of MCI among cognitively normal older adults. Neurology. 2020 10 20; 95(16):e2295-e2304. Weigand AJ, Bondi MW, Thomas KR, Campbell NL, Galasko DR, Salmon DP, Sewell D, Brewer JB, Feldman HH, Delano-Wood L, Alzheimer's Disease Neuroimaging Initiative. PMID: 32878992; PMCID: PMC7713781.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    48. Beyond PD-MCI: objectively defined subtle cognitive decline predicts future cognitive and functional changes. J Neurol. 2021 Jan; 268(1):337-345. Jones JD, Uribe C, Bunch J, Thomas KR. PMID: 32804281; PMCID: PMC7855683.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    49. Regional hyperperfusion in older adults with objectively-defined subtle cognitive decline. J Cereb Blood Flow Metab. 2021 05; 41(5):1001-1012. Thomas KR, Osuna JR, Weigand AJ, Edmonds EC, Clark AL, Holmqvist S, Cota IH, Wierenga CE, Bondi MW, Bangen KJ, Alzheimer’s Disease Neuroimaging Initiative. PMID: 32615887; PMCID: PMC8054731.
      View in: PubMed   Mentions: 29     Fields:    Translation:Humans
    50. Patterns of longitudinal cortical atrophy over 3 years in empirically derived MCI subtypes. Neurology. 2020 06 16; 94(24):e2532-e2544. Edmonds EC, Weigand AJ, Hatton SN, Marshall AJ, Thomas KR, Ayala DA, Bondi MW, McDonald CR, Alzheimer's Disease Neuroimaging Initiative. PMID: 32393648; PMCID: PMC7455336.
      View in: PubMed   Mentions: 18     Fields:    Translation:Humans
    51. Regional Hypoperfusion Predicts Decline in Everyday Functioning at Three-Year Follow-Up in Older Adults without Dementia. J Alzheimers Dis. 2020; 77(3):1291-1304. Sanchez DL, Thomas KR, Edmonds EC, Bondi MW, Bangen KJ, Alzheimer’s Disease Neuroimaging Initiative. PMID: 32831202; PMCID: PMC9491307.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    52. Evidence for the Utility of Actuarial Neuropsychological Criteria Across the Continuum of Normal Aging, Mild Cognitive Impairment, and Dementia. J Alzheimers Dis. 2020; 78(1):371-386. Graves LV, Edmonds EC, Thomas KR, Weigand AJ, Cooper S, Bondi MW. PMID: 32986674; PMCID: PMC7683095.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    53. Type 2 Diabetes Interacts With Alzheimer Disease Risk Factors to Predict Functional Decline. Alzheimer Dis Assoc Disord. 2020 Jan-Mar; 34(1):10-17. Thomas KR, Bangen KJ, Weigand AJ, Edmonds EC, Sundermann E, Wong CG, Eppig J, Werhane ML, Delano-Wood L, Bondi MW, Alzheimer’s Disease Neuroimaging Initiative. PMID: 31305320; PMCID: PMC6952586.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    54. Objective subtle cognitive difficulties predict future amyloid accumulation and neurodegeneration. Neurology. 2020 01 28; 94(4):e397-e406. Thomas KR, Bangen KJ, Weigand AJ, Edmonds EC, Wong CG, Cooper S, Delano-Wood L, Bondi MW, Alzheimer's Disease Neuroimaging Initiative. PMID: 31888974; PMCID: PMC7079691.
      View in: PubMed   Mentions: 61     Fields:    Translation:Humans
    55. Is tau in the absence of amyloid on the Alzheimer's continuum?: A study of discordant PET positivity. Brain Commun. 2020; 2(1):fcz046. Weigand AJ, Bangen KJ, Thomas KR, Delano-Wood L, Gilbert PE, Brickman AM, Bondi MW, Alzheimer’s Disease Neuroimaging Initiative. PMID: 32051933; PMCID: PMC7001143.
      View in: PubMed   Mentions: 36  
    56. Discrepancy-Based Evidence for Loss of Thinking Abilities (DELTA): Development and Validation of a Novel Approach to Identifying Cognitive Changes. J Int Neuropsychol Soc. 2020 05; 26(5):464-479. Asken BM, Thomas KR, Lee A, Davis JD, Malloy PF, Salloway SP, Correia S. PMID: 31822312.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    57. Pattern of regional white matter hyperintensity volume in mild cognitive impairment subtypes and associations with decline in daily functioning. Neurobiol Aging. 2020 02; 86:134-142. Bangen KJ, Thomas KR, Weigand AJ, Sanchez DL, Delano-Wood L, Edmonds EC, Carmichael OT, Schwarz CG, Brickman AM, Bondi MW, Alzheimer's Disease Neuroimaging Initiative. PMID: 31791658; PMCID: PMC6995428.
      View in: PubMed   Mentions: 17     Fields:    Translation:Humans
    58. Psychological Symptoms and Rates of Performance Validity Improve Following Trauma-Focused Treatment in Veterans with PTSD and History of Mild-to-Moderate TBI. J Int Neuropsychol Soc. 2020 01; 26(1):108-118. Jurick SM, Crocker LD, Merritt VC, Hoffman SN, Keller AV, Eglit GML, Thomas KR, Norman SB, Schiehser DM, Rodgers CS, Twamley EW, Jak AJ. PMID: 31658923.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    59. MCI-to-normal reversion using neuropsychological criteria in the Alzheimer's Disease Neuroimaging Initiative. Alzheimers Dement. 2019 10; 15(10):1322-1332. Thomas KR, Edmonds EC, Eppig JS, Wong CG, Weigand AJ, Bangen KJ, Jak AJ, Delano-Wood L, Galasko DR, Salmon DP, Edland SD, Bondi MW, Alzheimer's Disease Neuroimaging Initiative. PMID: 31495605; PMCID: PMC6801026.
      View in: PubMed   Mentions: 28     Fields:    Translation:Humans
    60. Mild traumatic brain injury characteristics do not negatively influence cognitive processing therapy attendance or outcomes. J Psychiatr Res. 2019 09; 116:7-13. Crocker LD, Jurick SM, Thomas KR, Keller AV, Sanderson-Cimino M, Hoffman SN, Boyd B, Rodgers C, Norman SB, Lang AJ, Twamley EW, Jak AJ. PMID: 31174014.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCTClinical Trials
    61. Cognitive dispersion is a sensitive marker for early neurodegenerative changes and functional decline in nondemented older adults. Neuropsychology. 2019 Jul; 33(5):599-608. Bangen KJ, Weigand AJ, Thomas KR, Delano-Wood L, Clark LR, Eppig J, Werhane ML, Edmonds EC, Bondi MW. PMID: 30896235; PMCID: PMC7380511.
      View in: PubMed   Mentions: 23     Fields:    Translation:Humans
    62. Early versus late MCI: Improved MCI staging using a neuropsychological approach. Alzheimers Dement. 2019 05; 15(5):699-708. Edmonds EC, McDonald CR, Marshall A, Thomas KR, Eppig J, Weigand AJ, Delano-Wood L, Galasko DR, Salmon DP, Bondi MW, Alzheimer's Disease Neuroimaging Initiative. PMID: 30737119; PMCID: PMC6511470.
      View in: PubMed   Mentions: 40     Fields:    Translation:Humans
    63. Artificially low mild cognitive impairment to normal reversion rate in the Alzheimer's Disease Neuroimaging Initiative. Alzheimers Dement. 2019 04; 15(4):561-569. Thomas KR, Eppig JS, Weigand AJ, Edmonds EC, Wong CG, Jak AJ, Delano-Wood L, Galasko DR, Salmon DP, Edland SD, Bondi MW, Alzheimer's Disease Neuroimaging Initiative. PMID: 30610833; PMCID: PMC6461519.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    64. SMART-CPT for veterans with comorbid post-traumatic stress disorder and history of traumatic brain injury: a randomised controlled trial. J Neurol Neurosurg Psychiatry. 2019 03; 90(3):333-341. Jak AJ, Jurick S, Crocker LD, Sanderson-Cimino M, Aupperle R, Rodgers CS, Thomas KR, Boyd B, Norman SB, Lang AJ, Keller AV, Schiehser DM, Twamley EW. PMID: 30554135.
      View in: PubMed   Mentions: 18     Fields:    Translation:Humans
    65. Neuropsychological Criteria for Mild Cognitive Impairment in the Framingham Heart Study's Old-Old. Dement Geriatr Cogn Disord. 2018; 46(5-6):253-265. Wong CG, Thomas KR, Edmonds EC, Weigand AJ, Bangen KJ, Eppig JS, Jak AJ, Devine SA, Delano-Wood L, Libon DJ, Edland SD, Au R, Bondi MW. PMID: 30391953; PMCID: PMC9049857.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    66. Computer and Videogame Interventions for Older Adults' Cognitive and Everyday Functioning. Games Health J. 2019 Apr; 8(2):129-143. Belchior P, Yam A, Thomas KR, Bavelier D, Ball KK, Mann WC, Marsiske M. PMID: 30273002; PMCID: PMC6482895.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    67. Reduced Regional Cerebral Blood Flow Relates to Poorer Cognition in Older Adults With Type 2 Diabetes. Front Aging Neurosci. 2018; 10:270. Bangen KJ, Werhane ML, Weigand AJ, Edmonds EC, Delano-Wood L, Thomas KR, Nation DA, Evangelista ND, Clark AL, Liu TT, Bondi MW. PMID: 30250430; PMCID: PMC6139361.
      View in: PubMed   Mentions: 53  
    68. Increasing Inaccuracy of Self-Reported Subjective Cognitive Complaints Over 24 Months in Empirically Derived Subtypes of Mild Cognitive Impairment. J Int Neuropsychol Soc. 2018 09; 24(8):842-853. Edmonds EC, Weigand AJ, Thomas KR, Eppig J, Delano-Wood L, Galasko DR, Salmon DP, Bondi MW. PMID: 30278855; PMCID: PMC6173206.
      View in: PubMed   Mentions: 34     Fields:    Translation:Humans
    69. Worse baseline executive functioning is associated with dropout and poorer response to trauma-focused treatment for veterans with PTSD and comorbid traumatic brain injury. Behav Res Ther. 2018 09; 108:68-77. Crocker LD, Jurick SM, Thomas KR, Keller AV, Sanderson-Cimino M, Boyd B, Rodgers C, Twamley EW, Jak AJ. PMID: 30031369.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    70. Word-list intrusion errors predict progression to mild cognitive impairment. Neuropsychology. 2018 02; 32(2):235-245. Thomas KR, Eppig J, Edmonds EC, Jacobs DM, Libon DJ, Au R, Salmon DP, Bondi MW, Alzheimer’s Disease Neuroimaging Initiative*. PMID: 29528684; PMCID: PMC5851458.
      View in: PubMed   Mentions: 31     Fields:    Translation:Humans
    71. The ACTIVE conceptual framework as a structural equation model. Exp Aging Res. 2018 Jan-Feb; 44(1):1-17. Gross AL, Payne BR, Casanova R, Davoudzadeh P, Dzierzewski JM, Farias S, Giovannetti T, Ip EH, Marsiske M, Rebok GW, Schaie KW, Thomas K, Willis S, Jones RN. PMID: 29303475; PMCID: PMC5793899.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    72. Using Neuropsychological Process Scores to Identify Subtle Cognitive Decline and Predict Progression to Mild Cognitive Impairment. J Alzheimers Dis. 2018; 64(1):195-204. Thomas KR, Edmonds EC, Eppig J, Salmon DP, Bondi MW, Alzheimer’s Disease Neuroimaging Initiative. PMID: 29865077; PMCID: PMC7263028.
      View in: PubMed   Mentions: 44     Fields:    Translation:Humans
    73. Differential Effect of APOE ɛ4 Status and Elevated Pulse Pressure on Functional Decline in Cognitively Normal Older Adults. J Alzheimers Dis. 2018; 62(4):1567-1578. Werhane ML, Thomas KR, Edmonds EC, Bangen KJ, Tran M, Clark AL, Nation DA, Gilbert PE, Bondi MW, Delano-Wood L, Alzheimer’s Disease Neuroimaging Initiative. PMID: 29562507.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    74. Compensatory cognitive training for people with severe mental illnesses in supported employment: A randomized controlled trial. Schizophr Res. 2019 01; 203:41-48. Twamley EW, Thomas KR, Burton CZ, Vella L, Jeste DV, Heaton RK, McGurk SR. PMID: 28823720; PMCID: PMC5816728.
      View in: PubMed   Mentions: 25     Fields:    Translation:Humans
    75. Self-perceived Difficulties in Everyday Function Precede Cognitive Decline among Older Adults in the ACTIVE Study. J Int Neuropsychol Soc. 2018 01; 24(1):104-112. Tomaszewski Farias S, Giovannetti T, Payne BR, Marsiske M, Rebok GW, Schaie KW, Thomas KR, Willis SL, Dzierzewski JM, Unverzagt F, Gross AL. PMID: 28797312; PMCID: PMC5750129.
      View in: PubMed   Mentions: 18     Fields:    Translation:Humans
    76. Cerebral Blood Flow and Amyloid-β Interact to Affect Memory Performance in Cognitively Normal Older Adults. Front Aging Neurosci. 2017; 9:181. Bangen KJ, Clark AL, Edmonds EC, Evangelista ND, Werhane ML, Thomas KR, Locano LE, Tran M, Zlatar ZZ, Nation DA, Bondi MW, Delano-Wood L. PMID: 28642699; PMCID: PMC5463038.
      View in: PubMed   Mentions: 33  
    77. Longitudinal Trajectories of Informant-Reported Daily Functioning in Empirically Defined Subtypes of Mild Cognitive Impairment. J Int Neuropsychol Soc. 2017 07; 23(6):521-527. Thomas KR, Edmonds EC, Delano-Wood L, Bondi MW. PMID: 28487004; PMCID: PMC5524519.
      View in: PubMed   Mentions: 20     Fields:    Translation:Humans
    78. Age and Improved Attention Predict Work Attainment in Combined Compensatory Cognitive Training and Supported Employment for People With Severe Mental Illness. J Nerv Ment Dis. 2016 Nov; 204(11):869-872. Puig O, Thomas KR, Twamley EW. PMID: 27798543; PMCID: PMC5117813.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    79. Age as a moderator of change following compensatory cognitive training in individuals with severe mental illnesses. Psychiatr Rehabil J. 2017 03; 40(1):70-78. Thomas KR, Puig O, Twamley EW. PMID: 27547856; PMCID: PMC5322254.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    80. Older Adults' Engagement During an Intervention Involving Off-the-Shelf Videogame. Games Health J. 2016 Jun; 5(3):151-6. Belchior P, Marsiske M, Leite WL, Yam A, Thomas K, Mann W. PMID: 27310479; PMCID: PMC5079422.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    81. Post-exercise pulse pressure is a better predictor of executive function than pre-exercise pulse pressure in cognitively normal older adults. Neuropsychol Dev Cogn B Aging Neuropsychol Cogn. 2016 07; 23(4):464-76. Scott BM, Maye J, Jones J, Thomas K, Mangal PC, Trifilio E, Hass C, Marsiske M, Bowers D. PMID: 26629911; PMCID: PMC4856549.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    82. CogSMART Compensatory Cognitive Training for Traumatic Brain Injury: Effects Over 1 Year. J Head Trauma Rehabil. 2015 Nov-Dec; 30(6):391-401. Twamley EW, Thomas KR, Gregory AM, Jak AJ, Bondi MW, Delis DC, Lohr JB. PMID: 25033034.
      View in: PubMed   Mentions: 27     Fields:    Translation:Humans
    83. Age trajectories of everyday cognition in African American and White older adults under prompted and unprompted conditions. Neuropsychol Rehabil. 2017 Jun; 27(4):522-539. Thomas KR, Marsiske M. PMID: 26480946; PMCID: PMC5031547.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    84. Race-related disparities in 5-year cognitive level and change in untrained ACTIVE participants. J Aging Health. 2013 Dec; 25(8 Suppl):103S-27S. Marsiske M, Dzierzewski JM, Thomas KR, Kasten L, Jones RN, Johnson KE, Willis SL, Whitfield KE, Ball KK, Rebok GW. PMID: 24385632; PMCID: PMC3882334.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    85. Verbal prompting to improve everyday cognition in MCI and unimpaired older adults. Neuropsychology. 2014 Jan; 28(1):123-34. Thomas KR, Marsiske M. PMID: 24219613; PMCID: PMC3935329.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    86. Identification of mild cognitive impairment in ACTIVE: algorithmic classification and stability. J Int Neuropsychol Soc. 2013 Jan; 19(1):73-87. Cook SE, Marsiske M, Thomas KR, Unverzagt FW, Wadley VG, Langbaum JB, Crowe M. PMID: 23095218; PMCID: PMC3573882.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    With one click, see people who:

    Mentor Faculty

    Run Clinical Trials

    See more options in the Advanced Search tab

    Kelsey's Networks
    Concepts (166)
    Derived automatically from this person's publications.
    Explore
    _
    Co-Authors (37)
    People in Profiles who have published with this person.
    Explore
    _
    Similar People (60)
    People who share similar concepts with this person.
    Explore
    _
    Same Department
    Search Department
    _

    UCSD Profiles is managed by the UC San Diego Altman Clinical and Translational Research Institute (ACTRI).
    This site is running Profiles RNS version UCSF-v3.1.0-3-g1ef1264b on PROFILES-PWEB04. We use cookies to operate our website. We also use cookies to analyze our site’s performance and improve your experience on our site. For more information about how we use cookies, please see our Website Terms of Use.

    Copyright © The Regents of the University of California